|
NEC Fingerprint Identification Contributes to the Provision of Legal Identity for Newborn Children in Developing Countries
TOKYO, Jun 20, 2019 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the successful conclusion of fingerprint identification technology trials with newborn children from as young as 2 to 24 hours old in the Republic of Kenya. This trial is expected to help establish a reliable foundation for biometric authentication of newborn children in emerging countries.
 | | Collection of newborn fingerprints ensures proper registration and identification | | |
The ability to collect and authenticate biometric information at an early age enables authorities to provide legal identity, including birth registration, for newborn children, ensures proper identification as they are discharged from the hospital, and supports the accurate management of vaccination schedules. This demonstration capitalized on continuous field research that began in 2016, resulting in an error rate of just 0.3%(1), and was carried out in coordination with the NUITM-KEMRI Project (Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute Project).
Currently, there are approximately 1 billion people worldwide without legal identity(2). In addition, an estimated 5.6 million children under the age of 5, including 2.6 million newborns, lose their lives each year. Most of these deaths are considered to be from illness that can be avoided through preventative measures and treatments(3).
In order to solve this problem, it is necessary to establish methods for registering and identifying newborn children as well as recording their medical history. This is especially important in regions where newborn children are often released from healthcare facilities in as few as 6 hours after birth. In addition to the importance of being able to verify the identity of children when they leave healthcare facilities, it is also vitally important to be able to confirm the vaccination schedules of children within 14 weeks of birth(4).
Moreover, as children grow and mature, this identification system can assist with ensuring that children are placed in schools at the most appropriate timing, leading to the advancement of educational opportunities.
NEC?s fingerprinting technology is designed to cause minimal stress for newborn children after caregivers have provided informed consent to taking their children's biometric data.
This initiative helps to promote the 17 Sustainable Development Goals (SDGs) established by the United Nations, particularly Goal 16, Target 16.9: By 2030, provide legal identity for all, including birth registration(5).
Going forward, NEC aims to provide this technology for practical use within biometric authentication infrastructure and national identity systems in emerging countries throughout the world. In addition, it hopes to centralize the authentication of patients who visit public hospitals and to enable convenient access to their medical history. This will help to minimize the loss of medical information and to prevent errors in treatment due to lack of patient information. This information may also contribute to the understanding of civil registration and vital statistics (CRVS) in the near future.
NEC has positioned the safety business centered on Bio-IDiom(6) as a global-growth engine in its 2020 Mid-term Management Plan, a three-year medium-term management plan up to FY2020. NEC has also strengthened business under the NEC Safer Cities(7) initiative. In the future, NEC will continue to focus on the Safety Business to expand its social solutions business.
Overview of technology enhancements in testing trials
Improved Imaging Accuracy
In order to collect the fingerprints of newborn children within a few hours of being born, NEC adopted a high-resolution image sensor with a high-resolution imaging element of 10 micrometers, and combined special glass for enhancing patterns. This made it possible to capture high-definition images of "valley line" patterns of approximately 20 micrometers.
Enhancement of imaging functions and design
In order to eliminate blurring due to the movement of newborn children's fingers during the fingerprint capturing process, the frame rate was increased from the previous 2 frames per second (fps) to a 7 fps rate, and the sensor area was equipped with a blurring prevention function. In addition, NEC adopted specialized equipment that is optimally designed for newborn children, featuring contours that ensure that children?s soft fingers are not pressed strongly against imaging surfaces and guides that ensure the most appropriate direction and position of a subject's finger.
(1) According to NEC research
(2) World Bank Group;
new windowhttp://www.worldbank.org/en/programs/id4d
(3) UNICEF; "Levels & Trends in Child Mortality Report 2017" P1, October 2017
(4) UNICEF; https://www.unicef.org/immunization/index_75054.html
(5) United Nations, "General assembly 15-15900 (E) "p.26, September 2015.
(6) Bio-IDiom
"Bio-IDiom" is NEC's portfolio of biometric identification solutions, including face, iris, fingerprint, palm print, finger vein, voice, and ear acoustic solutions.
https://www.nec.com/en/global/solutions/biometrics/index.html
(7) NEC Safer Cities:
NEC's business domain supporting the realization of safe, secure, efficient, and fair cities by utilizing advanced AI and IoT-related technologies, including biometric certification and video analysis. https://www.nec.com/en/global/solutions/safercities/index.html
Contact:NEC
Seiichiro Toda
s-toda@cj.jp.nec.com
+81-3-3798-6511
Source: NEC Corporation
Sectors: Electronics, CyberSecurity
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network. |
Latest Press Release
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST
|
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
| 
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
| 
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
| 
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST
| 
ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST
| 
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST
| 
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST
|
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST
| 
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST
| 
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST
| 
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
|
CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST
| 
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST
|
Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST
| 
Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST
|
COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST
|
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST
|
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST
|
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST
|
More Latest Release >>
|